| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/08/2007 | WO2007015167A2 Reducing interference between oil-containing adjuvants and surfactant-containing antigens |
| 02/08/2007 | WO2007014977A1 Recombinant vectors based on the modified vaccinia ankara (mva) virus as vaccines against leishmaniasis |
| 02/08/2007 | WO2007014772A2 Direct and indirect effector cell protease receptor-1 (epr-1) inhibitors as antiplatelet agents |
| 02/08/2007 | WO2007014743A2 Cd33-specific single-chain immunotoxin and method of use |
| 02/08/2007 | WO2007014460A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014459A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014458A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014457A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014456A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014455A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2006138248A3 Vaccines for protection from bartonella infection and related methods |
| 02/08/2007 | WO2006129162A3 Vaccine compositions and methods for the treatment of urinary incontinence |
| 02/08/2007 | WO2006128180A9 Methods for the treatment of disease |
| 02/08/2007 | WO2006127517A3 Pretreatment of a biological sample from an autoimmune disease subject |
| 02/08/2007 | WO2006121852A3 Anti-cd19 antibody therapy for autoimmune disease |
| 02/08/2007 | WO2006077442A3 Inhibition of islet amyloid polypeptide (iapp) aggregation for the treatment of type 2 diabetes |
| 02/08/2007 | WO2006076584A3 Kid31 and antibodies that bind thereto |
| 02/08/2007 | WO2006065975A8 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 02/08/2007 | WO2006060484A3 Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
| 02/08/2007 | WO2006050834A3 Antibodies against tenascin-c |
| 02/08/2007 | WO2006048174A3 Immunoglobulin fractions |
| 02/08/2007 | WO2005110490A8 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 02/08/2007 | US20070033669 Semaphorin gene family |
| 02/08/2007 | US20070032636 Chimeric retroviral Gag genes and screening assays |
| 02/08/2007 | US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 02/08/2007 | US20070032465 Pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha |
| 02/08/2007 | US20070032457 Combination therapy for cancer treatment |
| 02/08/2007 | US20070032426 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 02/08/2007 | US20070031921 Potent combinations of mrna transport elements |
| 02/08/2007 | US20070031904 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031903 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031896 Anti-CCR4 antibodies and methods of use therefor |
| 02/08/2007 | US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/08/2007 | US20070031882 Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules |
| 02/08/2007 | US20070031860 G-protein coupled receptor and uses therefor |
| 02/08/2007 | US20070031484 Immunoliposomes that optimize internationalization into target cells |
| 02/08/2007 | US20070031458 Recombinant Vibrio cholerae strain and vaccine comprising said strain |
| 02/08/2007 | US20070031457 Modified Bacillus anthracis, vaccine compositions and methods of use thereof |
| 02/08/2007 | US20070031456 Leptospirosis culture process |
| 02/08/2007 | US20070031455 expression vector; comprise a recombinant avipox virus containing a Nipah virus glycoprotein gene; used for vaccinating pigs against Nipah |
| 02/08/2007 | US20070031454 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 02/08/2007 | US20070031453 Modified influenza virus for monitoring and improving vaccine efficiency |
| 02/08/2007 | US20070031452 rheumatoid arthritis; nervous system disorders; endogenous retroviral elements (ERV) |
| 02/08/2007 | US20070031451 Inactivating pathogens with hydrogen peroxide for vaccine production |
| 02/08/2007 | US20070031450 Stabilizers for veterinary vaccines |
| 02/08/2007 | US20070031449 A Neisserial bacterium in which the expression of an Imp protein is functionally downregulated so that the level of lipopolysaccharide in the outer membrane is decreased compared to the wild-type; outer membrane vesicle preparations used as vaccines |
| 02/08/2007 | US20070031447 Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides |
| 02/08/2007 | US20070031446 Hcv vaccines |
| 02/08/2007 | US20070031445 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 02/08/2007 | US20070031444 Compounds targeted to cellular locations |
| 02/08/2007 | US20070031443 Methods for treating or preventing skin disorders using CD2-binding agents |
| 02/08/2007 | US20070031442 Method and compositions for boosting immune response |
| 02/08/2007 | US20070031441 Immunotherapy based on dendritic cells |
| 02/08/2007 | US20070031440 Modified transferin-antibody fusion proteins |
| 02/08/2007 | US20070031439 Novel protein related to melanoma-inhibiting protein and uses thereof |
| 02/08/2007 | US20070031438 Antibodies as chimeric effector cell receptors against tumor antigens |
| 02/08/2007 | US20070031437 Compositions and methods for modulating vascular development |
| 02/08/2007 | US20070031436 Bivalent monomeric Fv antibody formed by one single-chain Fv monomer having four variable domains; expression plasmids which code for an Fv antibody; diagnosis; stability; no undesired immune response; side effect reduction; lack constant domains |
| 02/08/2007 | US20070031435 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 02/08/2007 | US20070031434 Uses for Eph receptor antagonists and agonists |
| 02/08/2007 | US20070031433 Tumor antigen |
| 02/08/2007 | US20070031432 Tumor antigen |
| 02/08/2007 | US20070031431 polypeptides consisting of amino acid sequences or peptide fragments and drug carriers, used for inducing and/or activating human leukocyte antigens (HLA-A2)-restricted tumor-specific cytotoxic T lymphocytes; anticancer vaccines |
| 02/08/2007 | US20070031430 Varible domain of heavy chain antibodies; antitumor agents |
| 02/08/2007 | US20070031429 Cancerous desease modifying antibodies |
| 02/08/2007 | US20070031428 Isolated monoclonal antibody produced by hybridoma deposit IDAC accession number 170505-01; binding assays; customization of therapy for each individual |
| 02/08/2007 | US20070031427 Cancerous disease modifying antibodies |
| 02/08/2007 | US20070031426 Isolated monoclonal antibody produced by hybridoma deposit IDAC accession number 170505-03; binding bioassays; customization of therapy designed for each individual; anticarcinogenic-, -tumor and -metastasis agents |
| 02/08/2007 | US20070031425 Cancerous disease modifying antibodies |
| 02/08/2007 | US20070031424 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 02/08/2007 | US20070031423 inhibiting proliferation of a antigenmyeloma tumor cell expressing a ganglioside by contacting the cell with an antibody that specifically binds to the ganglioside; melanoma, myeloma, small cell lung cancer, thymic lymphoma, T-cell lymphoma, B-cell lymphoma, osteosarcoma, and acute T-cell leukemia |
| 02/08/2007 | US20070031422 Selection of cells expressing heteromeric polypeptides |
| 02/08/2007 | US20070031421 Inhibitors targeting osteoclast-associated protein |
| 02/08/2007 | US20070031420 MASP-2, a complement-fixing enzyme, and uses for it |
| 02/08/2007 | US20070031419 Methods and compositions for treating diseases targeting CDCP1 |
| 02/08/2007 | US20070031418 Methods for treating lower motor neuron diseases and compositions containing the same |
| 02/08/2007 | US20070031417 Dicer interacting proteins and uses therefor |
| 02/08/2007 | US20070031416 Use of antibody |
| 02/08/2007 | US20070031415 Regulation of interaction between rapl and rap1 |
| 02/08/2007 | US20070031414 DR5 antibodies and uses thereof |
| 02/08/2007 | US20070031413 Treatment with anti-vegf antibodies |
| 02/08/2007 | US20070031412 using activated factor X (FXa) effector; hemorrhagic diathesis; cardiovascular disorders |
| 02/08/2007 | US20070031411 Vaccine comprising a tick cement protein |
| 02/08/2007 | US20070031410 POP2: NFkB - Inhibiting Polypeptides, Nucleic Acids and Methods of Use |
| 02/08/2007 | US20070031409 Recombinant DNA-molecule complex for the expression of anti-human-interferon-gamma chimeric antibodies or antibody fragments |
| 02/08/2007 | US20070031408 Treating a subject afflicted with HIV-1 by administering anti-viral agent selected from a nonnucleoside reverse transcriptase inhibitor, a nucleoside reverse transcriptase inhibitor, a HIV-1 protease inhibitor, and a HIV-1 fusion or viral entry inhibitor |
| 02/08/2007 | US20070031407 Peptide or protein containing a C'-D loop of the CD28 receptor family |
| 02/08/2007 | US20070031406 Anti-thymocyte antiserum and use thereof to trigger b cell apoptosis |
| 02/08/2007 | US20070031405 Use of A33 antigens and jam-it |
| 02/08/2007 | US20070031404 Antibodies |
| 02/08/2007 | US20070031403 Monoclonal antibody used to purify the interferon-gamma inducing polypeptide; antitumor agents |
| 02/08/2007 | US20070031402 Immunoconjugate formulations |
| 02/08/2007 | US20070031382 Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
| 02/08/2007 | US20070031377 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity |
| 02/08/2007 | US20070031375 IL-16 antagonist peptides and DNA encoding the peptides |
| 02/08/2007 | US20070031335 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/08/2007 | US20070031331 Treatment of Disorders |
| 02/08/2007 | US20070031330 Isolated monoclonal antibody produced by the hybridoma; primary tumors and tumor metastases |
| 02/08/2007 | DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use |
| 02/08/2007 | CA2620937A1 Cancerous disease modifying antibodies |